Gamma-chymotrypsin (-yCHT) is an active modification of the bovine protease chymotrypsin' which has a molecular weight of approximately 25,000.2 It can be crystallized from half-saturated ammonium sulfate solutions in the space group P42212 with one molecule in the asymmetric unit. 3 Since there is evidence indicating that the enzyme molecules in this crystal are in an enzymatically active configuration,4 a detailed crystallographic structure determination would be of great interest.
In this study we have prepared a single site heavy atom derivative of -yCHT by crystallizing yCHT inhibited with p-iodobenzenesulfonyl fluoride (pipsyl-F, Fig. 1 ).
The position of the heavy atom, iodine, in the unit cell was determined by comparing the X-ray diffraction data from crystals of pipsyl--yCHT and crystals of yCHT inhibited with the analogous compound, p-methylbenzenesulfonyl fluoride (tosyl-F, Fig. 1 ). The use of tosyl-yCHT instead of the native enzyme as the parent protein clearly facilitated the location of the iodine atom by providing a higher degree of isomorphism. The isomorphous replacement was regarded as the stoichiometric substitution of an iodine atom for a methyl group. The iodine atom is a substituent of a group which we have demonstrated to be linked irreversibly to the active site of chymotrypsin. The pipsyl-'YCHT derivative therefore serves the dual purpose of providing a marker by which the active center of the enzyme may be localized crystallographically as well as providing a heavy atom derivative for the structure determination.
Materials and Mfethods.-Twice crystallized and lyophilized -yCHT (Worthington Biochemical Corp.) was used without further purification. Para-iodobenzenesulfonyl chloride (pipsyl-Cl) from Mfann Research Labs, Inc., was recrystallized once from n-hexane. 1n25-labeled pipsyl-Cl (Volk Radiochemical Corp.) was recrystallized to constant specific activity with 3 gm of cold pipsyl-Cl.
Synthesis of p-methylbenzenesulfonyl fluoride (tosyl-F): Tosyl-F was prepared from tosyl-Cl Synthesis of p-iodobenzenesulfonyl fluoride (pipsyl-F): Four gm (13.3 meq) of pipsyl-Cl and 0.58 gm of NaF (13.8 meq) were stirred in 5 ml of dry dimethylformamide at 90'C for 30 min.
The product was extracted with CH2Cl2 and recrystallized from cyclohexane (m.p. 83-84°, yield 32%). The product was further purified by sublimation (m.p. 860C; calculated: C, 25.2; F, 6.6; S, 11.2; I; 44.3; found: C, 25.4; F, 6.6; S 11.3; I, 44.0). Because of the lability of the ring-iodine bond, the procedure differs slightly from that outlined by Fahrney and Gold in that the conditions are less energetic and an excess of NaF is avoided. Pipsyl (I125)-F was prepared in an identical fashion using pipsyl(IlM)-Cl.
Preparation of pipsyl-yCHT and tosyl--yCHT: The method employed is a modification of the procedure used by Fahrney and Gold5 to inhibit chymotrypsin with phenylmethanesulfonyl fluoride. A 1% yCHT solution (4 X 10-4 M) in 0.05 phosphate buffer (pH 7.2) containing 10% 2-propanol was mixed with an equal volume of a 4.25 X 10-4 M sulfonyl fluoride solution in the same solvent and allowed to stand 2.5 hr at room temperature (99.0% inhibition). The protein solutions were lyophilized after extensive dialysis of the reaction mixture against 2 X 10-3 M cold acetic acid (pH 3.7). The inhibited enzyme was crystallized from a 1.25% protein solution half-saturated with (NH4)2SO4. Pipsyl(II25)-yCHT was prepared in the same way using pipsyl (J125)-F. Derivatives prepared from the sulfonyl fluorides were found to be more suitable for the preparation of protein crystals used in these crystallographic studies than derivatives prepared from the corresponding sulfonyl-Cl using methods similar to those introduced by Kallos and Rizok6 and Strumeyer et al.7 for the tosylation of -yCHT.
Enzyme concentrations were determined photometrically using e2905. = 1.66 mg ml-' cm-'.
This extinction coefficient was used rather than the conventional &2820.k since the pipsyl contribution to the absorbance is significant for X < 2850 A.
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The specific activity of I'a5 inhibitors was determined using standard solutions prepared by weighing out the solute (±0.2%). I125 activity was measured with a Packard automatic B-ray spectrometer. Enzymatic activity was assayed by the method of Hummel., Crystallographic studies: X-ray diffraction photographs were taken with a Buerger precession camera using CuKa radiation. The [hOt] and [hk0] data were collected to a resolution of approximately 4 A. Quartz calibrated photographs were used to determine the cell constants. The intensities of the reflections were determined with a Joyce-Loebl microdensitometer.
Results and Discussion.-Mole ratio of iodine:enzyme in crystals of pipsyl--yCHT: Crystals of pipsyl(IJ25)--yCHT were dissolved and exhaustively dialyzed. Enzymatic activity and protein bound 1125 radioactivity were measured in the dialysate. If one radioactive pipsyl group is bound per molecule of enzyme, then the specific radioactivities of the inhibitor and the inhibited protein should be identical. The comparison of specific activity of pipsyl(J'26)-F and pipsyl(1125)-yCHT presented below indicates that 0.98 atoms of iodine (as a pipsyl group) are irreversibly bound per molecule of enzyme (m.w. 25,000).2 Furthermore, the fact that the enzyme has lost 99.3 per cent of its enzymatic activity as a result of this stoichiometric interaction indicates that essentially one iodine (as a pipsyl group) has been bound to each enzyme molecule. The irreversible loss of enzymatic activity resulting from the stoichiometric interaction of pipsyl-F and yCHT suggests that pipsyl-F is covalently bonded to a residue at or near the active center. In addition we have demonstrated that pipsyl(I125)-F is prevented from reacting with yCHT previously inhibited by diisopropylfluorophosphate or tosyl-F (see below).
Gold Crystallographic studies: Unit cell dimensions of the native enzyme as well as the pipsyl and tosyl derivatives were determined and are given below. The tosyl and pipsyl derivatives differ noticeably from the native enzyme mainly in the c-axis dimension. The two inhibited derivatives, however, have virtually identical cell constants thereby satisfying one requirement for strict isomorphism.
The position of the iodine atom was obtained by comparing the diffraction data of pipsyl-"yCHT and tosyl-7CHT by means of the a-axis and c-axis difference Patterson projections shown in Figure 2a The Fourier map shown in Figure 3a represents the electron density distribution of the heavy atom (replacement) projected down the a-axis. It was computed using the differences between the observed structure amplitudes of the pipsyl and tosyl derivatives and the phases calculated from the coordinates of the iodine, as derived from the difference Patterson maps. Although the two heavy atoms in the asymmetric unit of this projection are clearly seen at (x,z) and (y,2), such an electron density map cannot, by itself, be used to verify the coordinates because of the overriding effect of the assigned phases. However, this projection can be treated as if PROC. N. A. S. it were orthorhombic for the purpose of calculating the phases, in which case either of the two positions can be introduced individually into the phase calculation. Thus, preliminary verification of the heavy atom coordinates was obtained by computing the a-axis Fourier projection phased with the (x,z) position alone (Fig.   3b ). The (y,2) peak remained (about 1/2 the peak height of the (x,z) peak) even though it was not used in the calculation of the phases. Similarly, if the Fourier series was phased with only the (y,2) position, the (x,z) peak remained (also about 1/2 the peak height of the (y,2) peak). In both cases the peak corresponding to the atom which was omitted from the calculation was at least double the highest background peak.
These results demonstrate that a crystalline heavy atom enzyme derivative of predictable stoichiometry can be produced in a chemically rational manner by taking advantage of the reactivity of the enzyme's active site. In addition, the localization of a heavy atom bearing a known chemical relationship to the active center may facilitate the structure determination of the active center. We have previously reported that levorphanol, a close structural analogue of morphine, inhibits RNA synthesis in E. coli to the extent of 80-90 per cent. 1 2 Since ribosomal RNA comprises 80-85 per cent of the total RNA of the cell, these results indicate that the synthesis of ribosomal RNA must be markedly inhibited by levorphanol. The present experiments were designed to determine the extent to which levorphanol inhibits the synthesis of messenger and transfer RNA. Evidence will be presented which demonstrates that levorphanol inhibits predominantly the synthesis of ribosomal RNA. This is in contrast to the findings with actinomycin D which has been shown to inhibit equally the synthesis of all types of cellular RNA.3 ,4 Materials and Methods.-Bacterial strains and media: E. coli K-13, a prototrophic isolate of strain K-12, and Hfr Hayes, a methionine requiring K-12 "relaxed" mutant, were used in the present experiments. Cells were grown in minimal medium buffered by 0.05 M triethanolamine at pH 8.2, supplemented with 0.5% sodium succinate and 0.2% casamino acids as sources of carbon as described previously.2 For the "step-down" experiment the enriched medium was prepared by adding 1% Difco Bacto-peptone to the minimal medium and readjusting the pH to 8.2.
Materials: 0-nitrophenyl fl-galactoside (ONPG) and isopropylthiogalactoside (IPTG) were purchased from Mann Laboratories, DNAase from Worthington Chemical Co. Levorphanol tartrate and levallorphan tartrate were made available through the generosity of Hoffmann-La Roche, Inc., Nutley, N.J. C14-uracil was purchased from New England Nuclear Corp.
